Emphasis on Drug Classes (Antibiotics, Alpha Agonists, Retinoid, Corticosteroids, Immunosuppressants, Other); Mode of Administration (Topical, Oral); Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drugstores, Online Sales); and Region/Country
The rosacea market is expected to register a CAGR of approx. 6% over the period of 2022-2028. Rosacea is a skin condition where a person’s skin turns red, and the blood vessels become visible. It is most common in middle-aged women and is frequently misdiagnosed as allergies, acne, or other skin infections. The affected areas of the body are the nose and cheeks. Rosacea symptoms include small, red, pus-filled bumps that may flare up from time to time. Eye dryness, irritation, and swollen, reddened eyelids are experienced by about half of rosacea patients. Other symptoms include nose skin thickening (rhinophyma) and an enlarged nose. Rosacea primarily affects middle-aged women with fair skin. The global rosacea market can be attributed to the increasing prevalence of rosacea among the global population. For instance, according to Medical News Today, in 2022, Rosacea is a chronic inflammatory condition affecting the skin. It typically causes visible and enlarged blood vessels of the face, redness, and small pus-filled bumps. Research estimates that around 5.46% of trusted source adults worldwide live with rosacea. Still, doctors may mistake its symptoms for acne or psoriasis. Owing to these glaring statistics the rosacea market is anticipated to grow in the forthcoming year due to the growing elderly population as the prevalence of rosacea increased significantly with age. Furthermore, the rosacea market is anticipated to grow on account of rise in the availability of generic medicines for rosacea. In addition, the increasing government initiatives and investments in the treatment market are likely to aid the market growth. However, some of the restraints in the market including low diagnosis despite high prevalence are impeding the growth of this market all over the world.
Bausch Health Companies Inc, Amorepacific Corporation, Bayer Schering AG, Nestlé (Galderma), Leo Pharma Inc, Hovione FarmaCiencia SA, Aclaris Therapeutics, Pfizer Inc., Sonoma Pharmaceuticals Inc., Mylan N.V, Inc are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst drug classes, the antibiotics category accounted for the significant share in the market in 2020”
Based on the drug classes, the rosacea market is segmented into antibiotics, alpha agonists, retinoid, corticosteroids, immunosuppressants, and others. The antibiotics segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe. For a long time, antibiotics have been used to treat the symptoms of rosacea. It has the ability to reduce the number of acne pimples as well as bacterial inflammation or redness around the acne pimples.
“Amongst mode of administration, the topical category is expected to witness considerable CAGR during the forecast period”
Based on mode of administration, the market is fragmented into topical and oral. The topical segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to Topical medications generally being prescribed as the first line of treatment form. Topical drugs are highly favored over other options because they are convenient and give better results.
“Amongst distribution channel, the hospitals pharmacies category is expected to witness considerable CAGR during the forecast period”
Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies & drug stores, and online sales. The hospital pharmacies segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe owing to the increased awareness of so many peoples about rosacea. Rosacea has no established origin. The patient suffering from rosacea gets good treatment in hospital and have fast recovery.
“North America to witness significant growth during the forecast period”
For a better understanding of the market dynamics of the rosacea market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the rosacea industry owing to the high government healthcare spending on pharmaceuticals and medical devices each year, as well as societal awareness and growing prevalence of cancer, availability of advanced treatment and as the disease tends to affect people with fair/light skin.
Reasons to buy this report:
Customization Options:
Global rosacea market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Research Methodology for the Global Rosacea Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global rosacea market were the three major steps undertaken to create and analyze the adoption of rosacea in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global rosacea market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the rosacea market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the rosacea market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as the drug classes, mode of administration, and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the rosacea market. Further, we conducted factor analysis using dependent and independent variables such as the increasing prevalence of rosacea globally. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the rosacea market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global rosacea market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global rosacea market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of drug class, mode of administration, and distribution channel in the global rosacea market.
The main objective of the Global Rosacea Market Study
The current & future market trends of the global rosacea market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought